|
Mutation Information
|
Mutation Site
|
T215Y |
|
Mutation Type
|
Amino acid level |
|
Gene/Protein/Region Type
|
RT |
|
Relevant Drug
|
thymidineanalogue (TAMs) |
|
Country
|
Uzbekistan |
Literature Information
|
PubMed PMID
|
32873061
|
|
Disease
|
HIV infection/AIDS
|
|
Published Year
|
2021 |
|
Journal
|
AIDS research and human retroviruses |
|
Title
|
Prevalence of Antiretroviral Drug Resistance Mutations Among Pretreatment and Antiretroviral Therapy-Failure HIV Patients in Uzbekistan. |
|
Author
|
Mamatkulov A,Kazakova E,Ibadullaeva N,Joldasova E,Bayjanov A,Musabaev E,Kan N,Mustafaeva D,Lebedev A,Bobkova M,Kazennova E,Zohrabyan L |
|
Evidence
|
Among the thymidine analogue mutations (TAMs), the highest prevalence was attributed to T215YF (8.5%;9/106), M41L (5.7%;6/106), D67N (3.8%;4/106), and K70R (3.8%;4/106). In total, TAMs accounted for 18.9% (20/106 of all samples).
|
|
|
HIV Mutation Detail Information